Defnom 6mg Tablet DEFLAZACORT

Introduction to Defnom 6mg Tablet

Defnom 6mg Tablet is a medication primarily used to treat a condition known as Duchenne muscular dystrophy (DMD) in children aged 5 and older. This condition leads to muscle weakening, and Defnom helps manage the symptoms effectively.

Composition of Defnom 6mg Tablet

The active ingredient in Defnom 6mg Tablet is Deflazacort. This component is crucial for its therapeutic effects, helping to reduce inflammation and suppress the immune system.

Uses of Defnom 6mg Tablet

• Management of Duchenne muscular dystrophy (DMD) in children.
• Reduction of inflammation in various conditions.
• Suppression of the immune system to prevent unwanted immune responses.

Side effects of Defnom 6mg Tablet

Common side effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious side effects:

• Allergic reactions such as rash, itching, or swelling
• Severe dizziness
• Trouble breathing

Precautions of Defnom 6mg Tablet

Defnom 6mg Tablet should not be taken by individuals who are allergic to Deflazacort or any of its ingredients. Caution is advised during pregnancy and breastfeeding. It is important not to stop taking Defnom suddenly, as this can lead to steroid withdrawal syndrome, which includes symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.

How to Take Defnom 6mg Tablet

• Take Defnom 6mg Tablet once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Defnom 6mg Tablet

Defnom 6mg Tablet is an effective medication for managing Duchenne muscular dystrophy in children. While it offers significant benefits, it is important to be aware of its side effects and precautions. Always follow your healthcare provider's instructions for the best results.